Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021 | 09/08/2021 | |
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) | 04/08/2021 | |
Holding gatherings during the COVID-19 pandemic: WHO policy brief | 03/08/2021 | |
Holding gatherings during the COVID-19 pandemic: WHO policy brief, 2 August 2021 | 03/08/2021 | |
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) | 30/07/2021 | |
Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) | 30/07/2021 | |
Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection | 15/07/2021 | |
WHO technical consultation on oxygen access scale-up for COVID-19 | 14/07/2021 | |
Safe Eid al Adha practices in the context of COVID-19 | 13/07/2021 | |
COVID-19 Vaccines: safety surveillance manual. Module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women | 12/07/2021 | |
Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed | 12/07/2021 | |
Therapeutics and COVID-19: living guideline | 06/07/2021 | |
Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19: Interim guidance | 02/07/2021 | |
Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19 | 02/07/2021 | |
Ethical Framework for WHO’s work in the ACT-Accelerator | 01/07/2021 | |
Protocol template to be used as template for observational study protocols for sentinel surveillance of adverse events of special interest (AESIs) after vaccination with COVID-19 vaccines. | 01/07/2021 | |
Implementation guidance for assessments of frontline service readiness: strengthening real-time monitoring of health services in the context of the COVID-19 pandemic | 01/07/2021 | |
Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities | 25/06/2021 | |
Indicator framework for the evaluation of the public health effectiveness of digital proximity tracing solutions | 25/06/2021 | |
Considerations for quarantine of contacts of COVID-19 cases | 25/06/2021 | |
Managing family risk: A facilitator’s toolbox for empowering families to manage risks during COVID-19 - Part 2 | 18/06/2021 | |
A family toolbox for managing health and happiness during COVID-19 - Part 1 | 18/06/2021 | |
Hypertension and COVID-19 | 17/06/2021 | |
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine | 15/06/2021 | |
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 | 15/06/2021 | |
Considerations for implementing and adjusting public health and social measures in the context of COVID-19 | 14/06/2021 | |
Update on WHO Interim recommendations on COVID-19 vaccination of pregnant and lactating women | 10/06/2021 | |
How to manage COVID-19 vaccines without VVM at vaccination service points? | 03/06/2021 | |
Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables | 01/06/2021 | |
Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines | 01/06/2021 | |
Use of medical and non-medical/fabric masks for community outreach activities during the COVID-19 pandemic | 01/06/2021 | |
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac | 01/06/2021 | |
Preventing and mitigating COVID-19 at work | 19/05/2021 | |
WHO COVID-19 infection prevention and control (IPC) pillar achievements. | 14/05/2021 | |
Programmatic innovations to address challenges in tuberculosis prevention and care during the COVID-19 pandemic | 13/05/2021 | |
AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine | 10/05/2021 | |
Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalizations associated with laboratory-confirmed SARS-CoV-2: an evaluation using the test-negative design | 06/05/2021 | |
COVID-19 Exercise Programme - Drills for Vaccine Deployment | 03/05/2021 | |
Guía clínica para la atención al paciente long covid/covid persistente | 01/05/2021 | |
Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief | 26/04/2021 | |
Expanding our understanding of post COVID-19 condition: report of a WHO webinar | 24/04/2021 | |
Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience) | 20/04/2021 | |
Asthma and COVID-19: scientific brief | 19/04/2021 | |
Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief | 19/04/2021 | |
Why are there extra doses of vaccine in the vaccine vial? | 16/04/2021 | |
WHO COVID-19 essential supplies forecasting tool (COVID-ESFT) | 14/04/2021 | |
Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets | 12/04/2021 | |
WHO COVID-19 infection prevention and control (IPC) pillar achievements. February 2020 – January 2021
| 06/04/2021 | |
NO HACER en vacunas contra la COVID-19 | 31/03/2021 | |
WHO-convened global study of origins of SARS-CoV-2: China Part | 30/03/2021 | |
Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine | 17/03/2021 | |
How to monitor and report COVID-19 vaccine side effects | 15/03/2021 | |
Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data | 03/03/2021 | |
WHO Living guideline: Drugs to prevent COVID-19 | 02/03/2021 | |
COVID-19 vaccine checklist | 01/03/2021 | |
Health worker communication for COVID-19 vaccination flow diagram | 01/03/2021 | |
Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2 | 17/02/2021 | |
Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19 | 15/02/2021 | |
Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca | 10/02/2021 | |
Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF) | 09/02/2021 | |
Criterios para descartar infección aguda por SARS-CoV-2 tras la vacunación | 08/02/2021 | |
Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2 | 07/02/2021 | |
Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance | 03/02/2021 | |
Background document on the mRNA-1273 vaccine (Moderna) against COVID-19 | 03/02/2021 | |
Administración de la vacuna frente a COVID-19 en pacientes candidatos y receptores de trasplantes de órganos sólidos. | 28/01/2021 | |
Las nuevas cepas del SARS-CoV-2, ¿qué se sabe? | 26/01/2021 | |
Recomendaciones FACME sobre vacunación COVID-19 y trasplante de órganos | 25/01/2021 | |
Actualización - Estrategia de vacunación frente a COVID-19 en España | 25/01/2021 | |
INTEGRACIÓN DE LA SECUENCIACIÓN GENÓMICA EN LA VIGILANCIA DELSARS-CoV-2 | 22/01/2021 | |
Actualización - Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19 | 22/01/2021 | |
Strategies for Optimizing the Supply of Isolation Gowns | 21/01/2021 | |
WHO public health research agenda for managing infodemics | 18/01/2021 | |
Sequencing of SARS-CoV-2 - Version 1 | 18/01/2021 | |
Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency | 15/01/2021 | |
Investigational COVID-19 Convalescent Plasma | 15/01/2021 | |
Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | 14/01/2021 | |
Posicionamiento de la Sociedad Española de inmunologia (SEI) sobre vacunación en pacientes que ya han superado la COVID-19 | 14/01/2021 | |
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines | 14/01/2021 | |
COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity | 13/01/2021 | |
Consideraciones acerca de las vacunas frente a la COVID-19 y la lactancia materna | 13/01/2021 | |
Recomendaciones FACME para la vacunación COVID-19 en niños y adolescentes | 12/01/2021 | |
Administración de la vacuna frente a COVID-19 en niños y adolescentes | 12/01/2021 | |
COVID-19 Rapid Response Team Guidance | 08/01/2021 | |
How to Make 0.1% Chlorine Solution to Disinfect Surfaces in Healthcare Settings | 08/01/2021 | |
Product Information as approved by the CHMP on 8 January 2021, pending endorsement by the European Commission | 08/01/2021 | |
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 - Version 3.6.0 | 08/01/2021 | |
¿Cómo atender a pacientes con COVID-19? | 07/01/2021 | |
Recomendaciones FACME para la vacunación frente a COVID-19 en alérgicos | 07/01/2021 | |
Recomendaciones FACME para la vacunación COVID-19 en alérgicos | 07/01/2021 | |
Providing Care and Treatment for People Living with HIV in Low-Resource Non-US Settings During COVID-19 Pandemic | 07/01/2021 | |
COVID-19 Vaccine Moderna - Product information | 06/01/2021 | |
CHMP summary of positive opinion for COVID-19 Vaccine Moderna | 06/01/2021 | |
Guidance on Providing Pediatric Well-Care During COVID-19 | 06/01/2021 | |
Summary of the Risk Management Plan for COVID-19 Vaccine Moderna | 06/01/2021 | |
COVID-19 Guidance for Safe Schools | 05/01/2021 | |
Interim Guidance on Supporting the Emotional and Behavioral Health Needs of Children, Adolescents, and Families During the COVID-19 Pandemic | 05/01/2021 | |
Resumen eficacia y seguridad vacuna Moderna | 05/01/2021 | |
Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication | 04/01/2021 | |
Guía Informativa para pacientes vacunas y vacunación COVID-19 | 04/01/2021 | |
Recomendaciones FACME para la vacunación COVID-19 en pacientes con cáncer | 30/12/2020 | |
Cloth Face Coverings | 30/12/2020 | |
Recomendaciones FACME para la vacunación COVID-19 durante la lactancia materna | 30/12/2020 | |
Guidance on the Use of Personal Protective Equipment (PPE) for Pediatric Care in Ambulatory Care Settings During the SARS-CoV-2 Pandemic | 30/12/2020 | |
COVID-19 Testing Guidance | 30/12/2020 | |
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 | 30/12/2020 | |
Information for Pediatric Healthcare Providers | 30/12/2020 | |
Recomendaciones FACME para la vacunación frente a COVID-19 en pacientes con cáncer | 30/12/2020 | |
Vacunas frente a COVID-19 y lactancia materna | 30/12/2020 | |
Recomendaciones FACME para la vacunación COVID-19 en mujeres embarazadas | 29/12/2020 | |
Recomendaciones FACME para la vacunación frente a COVID-19 en mujeres embarazadas | 29/12/2020 | |
La ciencia nos ha dado las vacunas, entro todos haremos que sean eficaces | 29/12/2020 | |
Recomendaciones FACME para la vacunación COVID-19 en pacientes inmunosuprimidos | 29/12/2020 | |
Recomendaciones FACME para la vacunación frente a COVID-19 en grupos de potencial riesgo | 29/12/2020 | |
Preguntas y respuestas relacionadas con las vacunas frente a la Covid-19 | 29/12/2020 | |
Recomendaciones FACME para la vacunación COVID-19 en pacientes anticoagulados o con trastornos de la coagulación | 29/12/2020 | |
Administración de la vacuna frente a COVID-19 en pacientes con inmunodeficiencias o en tratamiento inmunosupresor o inmunomodulador. | 29/12/2020 | |
Vacunación COVID-19 - Preguntas Comunes y Respuestas | 28/12/2020 | |
Etiquetado e indicaciones de seguridad para el uso y conservación de geles y soluciones hidroalcohólicos | 28/12/2020 | |
Recomendaciones y Posicionamiento sobre la vacunación frente a COVID-19 de la SEIMC en la población general y en particular en los más vulnerables | 27/12/2020 | |
Vacunación de la covid en el embarazo y lactancia | 23/12/2020 | |
COVID-19 in children and the role of school settings in transmission - Version 1 | 23/12/2020 | |
Comirnaty : EPAR - All authorised presentations | 22/12/2020 | |
Comirnaty : EPAR - Public assessment report | 22/12/2020 | |
Posicionamiento y recomendaciones de la Sociedad Española de Inmunología en relación con la campaña de vacunación frente a COVID-19 en pacientes con inmunodeficiencias primarias o secundarias | 22/12/2020 | |
Vigilancia de la seguridad de las vacunas frente a la COVID-19 | 22/12/2020 | |
Fundamento del uso de tocilizumab en pacientes con Covid. Beneficio vs riesgo - Versión 1 | 22/12/2020 | |
Commission adopts Recommendation on EU coordinated approach to travel and transport in response to new variant of coronavirus in the UK | 22/12/2020 | |
COVID-19 vaccination and prioritisation strategies in the EU/EEA | 22/12/2020 | |
Comirnaty: EPAR - Product Information | 21/12/2020 | |
Recomendaciones GESITRA-IC-SEIMC-REIPI para el manejo clínico de receptores de trasplante de órgano sólido con COVID-19 | 21/12/2020 | |
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 | 21/12/2020 | |
Información sobre productos sanitarios especialmente utilizados durante la COVID-19 que han sido detectados en el mercado y no cumplen la regulación | 21/12/2020 | |
Papel del remdesivir en pacientes con Covid-19 - Versión 1 | 21/12/2020 | |
CHMP summary of positive apinion for Comirnaty | 20/12/2020 | |
COVID-19 rapid guideline: managing the long-term effects of COVID-19 | 18/12/2020 | |
Coronavirus (covid-19): medidas de prevención y control de la infección | 18/12/2020 | |
Since advice in a crisis | 18/12/2020 | |
Proposal for a council recommendation on a common framework for the use, validation and mutual recognition of COVID-19 rapid antigen tests in the EU | 18/12/2020 | |
Vaccines and Related Biological Products Advisory Committee Meeting | 17/12/2020 | |
Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities | 17/12/2020 | |
COVID-19 rapid guideline: vitamin D | 17/12/2020 | |
Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities | 16/12/2020 | |
Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19 | 15/12/2020 | |
Mitigating Staff Shortages | 14/12/2020 | |
Testing Healthcare Personnel | 14/12/2020 | |
Potential Exposure at Work | 14/12/2020 | |
Infection Control Guidance | 14/12/2020 | |
Navidad segura con las recomendaciones SEIMC | 14/12/2020 | |
El coronavirus, un invitado no deseado. Diez sensatas recomendaciones para estas fechas | 14/12/2020 | |
Coronavirus (COVID-19): evidencia relevante para cuidados críticos | 12/12/2020 | |
Resumen, eficacia y seguridad vacuna Oxford-AstraZeneca | 12/12/2020 | |
Coronavirus disease 2019 (COVID-19) and supply ofsubstances of human origin in the EU/EEA - 2nd update | 10/12/2020 | |
Posicionamiento SEIMC sobre "Pruebas de detección rápida de anticuerpos por inmunocromatografia para el autodiagnóstico de infección por SARS-CoV-2 (Covid-19)" | 09/12/2020 | |
Tests ràpids d’infeccions respiratòries pediàtriques | 09/12/2020 | |
Obesity Management and Treatment During COVID-19 | 09/12/2020 | |
Supporting Healthy Nutrition and Physical Activity During the COVID-19 Pandemic | 09/12/2020 | |
Recomendaciones SEIMC para elmanejo clínico de pacientes con COVID-19 | 09/12/2020 | |
Comunicado oficial tras la recomendación de la agencia reguladora de medicamentos y productos sanitarios de reino unido de no poner la vacuna contra la COVID-19 de Pfizer a aquellos que tienen antecedentes de reacciones graves a fármacos y/o alimentos | 09/12/2020 | |
Winter Holidays | 09/12/2020 | |
Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19) | 08/12/2020 | |
Interim Guidance for Antigen Testing for SARS-CoV-2 | 05/12/2020 | |
COVID-19 Interim Guidance: Return to Sports | 04/12/2020 | |
Guidance for Dental Settings | 04/12/2020 | |
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths | 04/12/2020 | |
Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings | 03/12/2020 | |
Care for Breastfeeding Women | 03/12/2020 | |
Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel | 02/12/2020 | |
Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol | 02/12/2020 | |
Breastfeeding Guidance Post Hospital Discharge for Mothers or Infants with Suspected or Confirmed SARS-Co V-2 Infection | 02/12/2020 | |
Guidance for Health Departments about COVID-19 Testing in the Community | 01/12/2020 | |
Staying safe from COVID-19 during winter | 01/12/2020 | |
Gestió de casos COVID-19 als centres educatius | 01/12/2020 | |
Medidas de protección personal frente al coronavirus SARS-CoV-2: conceptos sobre su utilización en el ámbito laboral | 01/12/2020 | |
CDC Guidance for Expanded Screening Testing to Reduce Silent Spread of SARS-CoV-2 | 01/12/2020 | |
Know When to Delay your Travel to Avoid Spreading COVID-19 | 01/12/2020 | |
Guia para la prevenció y control de la COVID-19 en industrias de la carne | 30/11/2020 | |
Recomendaciones de la AEP para la consideración de los niños en las reuniones de Navidad en el contexto de la pandemia | 30/11/2020 | |
Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel | 30/11/2020 | |
Rapid hospital readiness checklist: Interim Guidance | 26/11/2020 | |
Uso de los test rápidos de antígeno para el diagnóstico de la infección SARS-CoV-2 traducido por el Consejo de Dentistas | 26/11/2020 | |
Know When to Delay your Travel to Avoid Spreading COVID-19 | 25/11/2020 | |
Contact Tracing for COVID-19 | 23/11/2020 | |
Prioritizing Case Investigations and Contact Tracing for COVID-19 in High Burden Jurisdictions | 23/11/2020 | |
Investigating a COVID-19 Case | 23/11/2020 | |
Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings | 23/11/2020 | |
Strategies for Optimizing the Supply of N95 Respirators | 23/11/2020 | |
Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings | 23/11/2020 | |
Polling Locations and Voters | 23/11/2020 | |
Strategies for Optimizing the Supply of Facemasks | 23/11/2020 | |
Collection and Submission of Postmortem Specimens from Deceased Persons with Known or Suspected COVID-19 | 22/11/2020 | |
COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19 | 20/11/2020 | |
Therapeutics and COVID-19: living guideline - 2nd Version | 20/11/2020 | |
Priority medical devices list for the COVID-19 response and associated technical specifications | 20/11/2020 | |
Preparing for COVID-19 in Nursing Homes | 20/11/2020 | |
Continuity of essential health services: Facility assessment tool | 20/11/2020 | |
Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 | 20/11/2020 | |
Operational Considerations for Personal Protective Equipment in the Context of Global Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic: non-US Healthcare Settings | 19/11/2020 | |
Actualización - Guía de test COVID-19 del Consejo General de Dentistas de España | 19/11/2020 | |
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK | 19/11/2020 | |
Cleaning, Disinfection, and Hand Hygiene in Schools – a Toolkit for School Administrators | 19/11/2020 | |
| | |
